This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: F. Hoffmann-La Roche Ag, Prothena Biosciences Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Jay Soto - Innovator in Synucleinopathies Treatment
Introduction
Jay Soto is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of medical treatment, particularly focusing on synucleinopathies. His innovative work has led to the development of a patent that addresses critical aspects of treatment regimens.
Latest Patents
Jay Soto holds a patent titled "Dosing Regimes for Treatment of Synucleinopathies." This patent represents his commitment to advancing medical science and improving patient outcomes through innovative treatment strategies. He has successfully secured 1 patent in this area.
Career Highlights
Throughout his career, Jay has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with F. Hoffmann-La Roche AG and Prothena Biosciences Limited. His experience in these organizations has enriched his expertise and contributed to his innovative endeavors.
Collaborations
Jay Soto has collaborated with esteemed professionals in his field, including Daniel Keith Ness and Martin Koller. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in treatment methodologies.
Conclusion
Jay Soto's contributions to the treatment of synucleinopathies through his patent and collaborations with leading companies and professionals highlight his role as an influential inventor in the medical field. His work continues to pave the way for future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile